Chemotherapy-induced mucositis: focusing on diarrhea.
Wisinski
Kari
K
Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Benson
Al
A
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D019819:Budesonide / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D003681:Dehydration / Q000517:prevention & control; D003967:Diarrhea / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D005472:Fluorouracil / Q000009:adverse effects; D005753:Gastric Mucosa / Q000187:drug effects; D041981:Gastrointestinal Tract / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects; D000077146:Irinotecan; D002955:Leucovorin / Q000009:adverse effects; D008139:Loperamide / Q000627:therapeutic use; D051379:Mice; D052016:Mucositis / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D009944:Organoplatinum Compounds / Q000009:adverse effects; D051381:Rats
D009944:Organoplatinum Compounds; D019819:Budesonide; D008139:Loperamide; D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin